RE:RE:Why today? Why on Friday?W8asec, maybe you forgot something here. The main shareholder of Nantpharma, is Dr Soon. Dr Soon is a main shareholder also in Prometic. For him, it's either the left Pocket, or the right Pocket. This decision is strategic, as what is Prometic is doing the best is exactly what Nantpro is doing, working on proteins. So why letting Nantpharma doing the job, when your best player which is Prometic can do it. Prometic will take the lead simply because Dr Soon thinks it's the best way to advance the project.